MET and cholangiocarcinoma: Here, we enumerated and analyzed CTCs from a cholangiocarcinoma patient using the epithelial marker EPCAM (Figure 5A) and the non-epithelial markers vimentin (Figure 5B) and MET (Figure 5C).